Conmed (CNMD) Tops Q3 EPS by 65c

Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.88, $0.65 better than the analyst estimate of $0.23. Revenue for the quarter came in at $237.8 million versus the consensus estimate of $205.92 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
• Kamada Ltd. (KMDA) Tops Q2 EPS by 4c